| Reference : Insulin-like growth factor 2 (IGF-2) is the dominant thymic peptide of the insulin family |
| Scientific congresses and symposiums : Unpublished conference | |||
| Human health sciences : Endocrinology, metabolism & nutrition Human health sciences : Immunology & infectious disease | |||
| http://hdl.handle.net/2268/24233 | |||
| Insulin-like growth factor 2 (IGF-2) is the dominant thymic peptide of the insulin family | |
| English | |
Geenen, Vincent [Université de Liège - ULg > > Centre d'immunologie - Embryologie >] | |
| Mar-1994 | |
| No | |
| Yes | |
| International | |
| Antigen-specific therapies in the prevention of type 1 diabetes | |
| George S. Eisenbart, Juvenile Diabetes Research Foundation | |
| San Francisco | |
| USA | |
| Juvenile Diabetes Research Foundation ; Fonds de la Recherche Scientifique (Communauté française de Belgique) - F.R.S.-FNRS | |
| http://hdl.handle.net/2268/24233 |
There is no file associated with this reference.
All documents in ORBi are protected by a user license.